Cargando…

In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells

Hepatotoxicity remains an as yet unsolved problem for adenovirus (Ad) cancer therapy. The toxic effects originate both from rapid Kupffer cell (KCs) death (early phase) and hepatocyte transduction (late phase). Several host factors and capsid components are known to contribute to hepatotoxicity, how...

Descripción completa

Detalles Bibliográficos
Autores principales: Naumenko, Victor A., Vishnevskiy, Daniil A., Stepanenko, Aleksei A., Sosnovtseva, Anastasiia O., Chernysheva, Anastasiia A., Abakumova, Tatiana O., Valikhov, Marat P., Lipatova, Anastasiia V., Abakumov, Maxim A., Chekhonin, Vladimir P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313019/
https://www.ncbi.nlm.nih.gov/pubmed/35885002
http://dx.doi.org/10.3390/biomedicines10071697
_version_ 1784753976312332288
author Naumenko, Victor A.
Vishnevskiy, Daniil A.
Stepanenko, Aleksei A.
Sosnovtseva, Anastasiia O.
Chernysheva, Anastasiia A.
Abakumova, Tatiana O.
Valikhov, Marat P.
Lipatova, Anastasiia V.
Abakumov, Maxim A.
Chekhonin, Vladimir P.
author_facet Naumenko, Victor A.
Vishnevskiy, Daniil A.
Stepanenko, Aleksei A.
Sosnovtseva, Anastasiia O.
Chernysheva, Anastasiia A.
Abakumova, Tatiana O.
Valikhov, Marat P.
Lipatova, Anastasiia V.
Abakumov, Maxim A.
Chekhonin, Vladimir P.
author_sort Naumenko, Victor A.
collection PubMed
description Hepatotoxicity remains an as yet unsolved problem for adenovirus (Ad) cancer therapy. The toxic effects originate both from rapid Kupffer cell (KCs) death (early phase) and hepatocyte transduction (late phase). Several host factors and capsid components are known to contribute to hepatotoxicity, however, the complex interplay between Ad and liver cells is not fully understood. Here, by using intravital microscopy, we aimed to follow the infection and immune response in mouse liver from the first minutes up to 72 h post intravenous injection of three Ads carrying delta-24 modification (Ad5-RGD, Ad5/3, and Ad5/35). At 15–30 min following the infusion of Ad5-RGD and Ad5/3 (but not Ad5/35), the virus-bound macrophages demonstrated signs of zeiosis: the formation of long-extended protrusions and dynamic membrane blebbing with the virus release into the blood in the membrane-associated vesicles. Although real-time imaging revealed interactions between the neutrophils and virus-bound KCs within minutes after treatment, and long-term contacts of CD8+ T cells with transduced hepatocytes at 24–72 h, depletion of neutrophils and CD8+ T cells affected neither rate nor dynamics of liver infection. Ad5-RGD failed to complete replicative cycle in hepatocytes, and transduced cells remained impermeable for propidium iodide, with a small fraction undergoing spontaneous apoptosis. In Ad5-RGD-immune mice, the virus neither killed KCs nor transduced hepatocytes, while in the setting of hepatic regeneration, Ad5-RGD enhanced liver transduction. The clinical and biochemical signs of hepatotoxicity correlated well with KC death, but not hepatocyte transduction. Real-time in vivo tracking for dynamic interactions between virus and host cells provides a better understanding of mechanisms underlying Ad-related hepatotoxicity.
format Online
Article
Text
id pubmed-9313019
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93130192022-07-26 In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells Naumenko, Victor A. Vishnevskiy, Daniil A. Stepanenko, Aleksei A. Sosnovtseva, Anastasiia O. Chernysheva, Anastasiia A. Abakumova, Tatiana O. Valikhov, Marat P. Lipatova, Anastasiia V. Abakumov, Maxim A. Chekhonin, Vladimir P. Biomedicines Article Hepatotoxicity remains an as yet unsolved problem for adenovirus (Ad) cancer therapy. The toxic effects originate both from rapid Kupffer cell (KCs) death (early phase) and hepatocyte transduction (late phase). Several host factors and capsid components are known to contribute to hepatotoxicity, however, the complex interplay between Ad and liver cells is not fully understood. Here, by using intravital microscopy, we aimed to follow the infection and immune response in mouse liver from the first minutes up to 72 h post intravenous injection of three Ads carrying delta-24 modification (Ad5-RGD, Ad5/3, and Ad5/35). At 15–30 min following the infusion of Ad5-RGD and Ad5/3 (but not Ad5/35), the virus-bound macrophages demonstrated signs of zeiosis: the formation of long-extended protrusions and dynamic membrane blebbing with the virus release into the blood in the membrane-associated vesicles. Although real-time imaging revealed interactions between the neutrophils and virus-bound KCs within minutes after treatment, and long-term contacts of CD8+ T cells with transduced hepatocytes at 24–72 h, depletion of neutrophils and CD8+ T cells affected neither rate nor dynamics of liver infection. Ad5-RGD failed to complete replicative cycle in hepatocytes, and transduced cells remained impermeable for propidium iodide, with a small fraction undergoing spontaneous apoptosis. In Ad5-RGD-immune mice, the virus neither killed KCs nor transduced hepatocytes, while in the setting of hepatic regeneration, Ad5-RGD enhanced liver transduction. The clinical and biochemical signs of hepatotoxicity correlated well with KC death, but not hepatocyte transduction. Real-time in vivo tracking for dynamic interactions between virus and host cells provides a better understanding of mechanisms underlying Ad-related hepatotoxicity. MDPI 2022-07-13 /pmc/articles/PMC9313019/ /pubmed/35885002 http://dx.doi.org/10.3390/biomedicines10071697 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Naumenko, Victor A.
Vishnevskiy, Daniil A.
Stepanenko, Aleksei A.
Sosnovtseva, Anastasiia O.
Chernysheva, Anastasiia A.
Abakumova, Tatiana O.
Valikhov, Marat P.
Lipatova, Anastasiia V.
Abakumov, Maxim A.
Chekhonin, Vladimir P.
In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
title In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
title_full In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
title_fullStr In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
title_full_unstemmed In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
title_short In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
title_sort in vivo tracking for oncolytic adenovirus interactions with liver cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313019/
https://www.ncbi.nlm.nih.gov/pubmed/35885002
http://dx.doi.org/10.3390/biomedicines10071697
work_keys_str_mv AT naumenkovictora invivotrackingforoncolyticadenovirusinteractionswithlivercells
AT vishnevskiydaniila invivotrackingforoncolyticadenovirusinteractionswithlivercells
AT stepanenkoalekseia invivotrackingforoncolyticadenovirusinteractionswithlivercells
AT sosnovtsevaanastasiiao invivotrackingforoncolyticadenovirusinteractionswithlivercells
AT chernyshevaanastasiiaa invivotrackingforoncolyticadenovirusinteractionswithlivercells
AT abakumovatatianao invivotrackingforoncolyticadenovirusinteractionswithlivercells
AT valikhovmaratp invivotrackingforoncolyticadenovirusinteractionswithlivercells
AT lipatovaanastasiiav invivotrackingforoncolyticadenovirusinteractionswithlivercells
AT abakumovmaxima invivotrackingforoncolyticadenovirusinteractionswithlivercells
AT chekhoninvladimirp invivotrackingforoncolyticadenovirusinteractionswithlivercells